Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects

Over the last 10 years, the diagnosis small fiber neuropathy (SFN) has gained recognition worldwide. Patients often suffer from severe neuropathic pain that may be difficult to treat. A substantial subset of patients with SFN is aged 65 years or older, and these patients often exhibit comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Brigitte A., de Greef, Bianca T. A., Hoeijmakers, Janneke G. J., Geerts, Margot, van Kleef, Maarten, Merkies, Ingemar S. J., Faber, Catharina G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548010/
https://www.ncbi.nlm.nih.gov/pubmed/26239827
http://dx.doi.org/10.1007/s40266-015-0283-8
Descripción
Sumario:Over the last 10 years, the diagnosis small fiber neuropathy (SFN) has gained recognition worldwide. Patients often suffer from severe neuropathic pain that may be difficult to treat. A substantial subset of patients with SFN is aged 65 years or older, and these patients often exhibit comorbidities and usage of multiple drugs, making neuropathic pain treatment more challenging. In this review, we highlight relevant pathophysiological aspects and discuss currently used therapeutic strategies for neuropathic pain. Possible pitfalls in neuropathic pain treatment in the elderly will be underlined.

Ejemplares similares